Metabolites and anti-inflammatory activities of Monascus sanguineus.
10.19540/j.cnki.cjcmm.20250522.201
- Author:
Ji-Yuan FAN
1
;
Bing-Yu LIU
2
;
Hui-Ming HUA
3
;
You-Cai HU
2
Author Information
1. School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University Shenyang 110016, China Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica,Chinese Academy of Medical Sciences & Peking Union Medical College Beijing 100050, China.
2. Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica,Chinese Academy of Medical Sciences & Peking Union Medical College Beijing 100050, China.
3. School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University Shenyang 110016, China.
- Publication Type:Journal Article
- Keywords:
Monascus sanguineus;
polyketides;
secondary metabolite;
structural identification
- MeSH:
Monascus/chemistry*;
Mice;
Animals;
Anti-Inflammatory Agents/isolation & purification*;
RAW 264.7 Cells;
Macrophages/immunology*;
Nitric Oxide/immunology*;
Oryza/metabolism*;
Fermentation
- From:
China Journal of Chinese Materia Medica
2025;50(13):3699-3735
- CountryChina
- Language:Chinese
-
Abstract:
A variety of chromatographic techniques, including silica gel, ODS, Sephadex LH-20, and HPLC, were employed to isolate and purify the fermentation products of rice with Monascus sanguineus. A total of 38 compounds were isolated, and their structures were identified by UV, IR, NMR, MS, calculated ECD, and comparison with literature data. Compounds 1-4 were identified as new natural products, and other compounds were isolated from this fungus for the first time. A RAW264.7 macrophage model of lipopolysaccharide(LPS)-induced inflammation was used to evaluate the anti-inflammatory activities of all the compounds. The results showed that compound 6 exhibited a certain inhibitory effect on the production of nitric oxide in LPS-induced RAW264.7 cells, with an inhibition rate of 53.08%.
